Cowen And Company, LLC Amarin Corp Plcuk Transaction History

Cowen And Company, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$2.85 - $3.73 $170,583 - $223,255	-59,854 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$3.24 - $5.18 $165,923 - $265,272	51,211 Added 592.51%	59,854 $202,000
Q3 2021 Nov 12, 2021	BUY	$3.94 - $5.84 $34,053 - $50,475	8,643 New	8,643 $44,000
Q1 2021 May 04, 2021	SELL	$5.03 - $8.8 $123,863 - $216,700	-24,625 Closed	0 $0
Q4 2020 Feb 08, 2021	SELL	$4.04 - $5.31 $163,228 - $214,539	-40,403 Reduced 62.13%	24,625 $120,000
Q3 2020 Nov 03, 2020	SELL	$3.64 - $7.76 $564,098 - $1.2 Million	-154,972 Reduced 70.44%	65,028 $274,000
Q1 2020 May 11, 2020	BUY	$4.0 - $21.53 $231,744 - $1.25 Million	57,936 Added 35.75%	220,000 $880,000
Q4 2019 Feb 11, 2020	BUY	$13.94 - $24.12 $2.06 Million - $3.57 Million	147,863 Added 1041.22%	162,064 $3.48 Million
Q3 2019 Nov 12, 2019	BUY	$13.89 - $23.16 $197,251 - $328,895	14,201 New	14,201 $215,000

177

65.1M

258K

98K

Ticker AMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 403,206,016
Market Cap $222M
Description
Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...

Get notified when there are updates to the investment portfolio of Cowen And Company, LLC, based on Form 13F filings with the SEC.

Stay updated on Cowen And Company, LLC with notifications on news.